MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q1
hinzugefügt 14.05.2026
Aurora Cannabis DPO 2011-2026 | ACB
DPO Jährlich Aurora Cannabis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | -807 | - | - | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -807 | -807 | -807 |
DPO anderer Aktien in der Arzneimittelhersteller
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
39.3 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
5.36 K | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
889 | $ 5.6 | -1.23 % | $ 83.2 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
38 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
4.75 K | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
345 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
116 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
352 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
309 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
212 | $ 2.68 | -2.55 % | $ 1.03 B |  Canada |
 |
Athenex
ATNX
|
111 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
199 | $ 37.64 | -0.03 % | $ 1.38 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
224 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
41.8 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
75.6 | - | -39.89 % | $ 27.7 M | USA |
 |
Canopy Growth Corporation
CGC
|
52.8 | $ 1.0 | -0.99 % | $ 108 M | Canada |
 |
Organogenesis Holdings
ORGO
|
94 | $ 2.34 | -1.68 % | $ 297 M | USA |
 |
Pacira BioSciences
PCRX
|
37.3 | $ 22.99 | -1.58 % | $ 1.06 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
32.3 | $ 1.09 | -0.91 % | $ 1.35 M | USA |
 |
Jupiter Wellness
JUPW
|
318 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
36.8 | - | 1.15 % | $ 7.11 M | USA |
 |
Tilray
TLRY
|
53 | $ 4.98 | -2.73 % | $ 3.08 B | Canada |
 |
cbdMD
YCBD
|
68.6 | $ 0.69 | -1.72 % | $ 2.78 M | USA |
 |
Evolus
EOLS
|
59.4 | $ 6.73 | 3.38 % | $ 434 M | USA |
 |
Emergent BioSolutions
EBS
|
65.2 | $ 8.32 | -0.83 % | $ 445 M | USA |
 |
Veru
VERU
|
251 | $ 3.0 | -7.98 % | $ 43.9 M | USA |
 |
Assertio Holdings
ASRT
|
122 | $ 23.48 | 0.04 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
845 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
274 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
78.1 | $ 5.06 | -1.94 % | $ 1.88 B | Canada |
 |
PetIQ
PETQ
|
54.2 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
6.63 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
109 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
20.2 | $ 4.23 | -0.35 % | $ 211 M | USA |
 |
Viatris
VTRS
|
70.9 | $ 16.48 | 1.04 % | $ 19.2 B | USA |
 |
Zomedica Corp.
ZOM
|
64.3 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
15.4 | $ 0.62 | 0.35 % | $ 22.3 M | USA |
 |
China Pharma Holdings
CPHI
|
47.6 | $ 0.71 | -6.82 % | $ 3.05 M |  China |
 |
TherapeuticsMD
TXMD
|
723 | $ 2.2 | 20.88 % | $ 25.5 M | USA |